Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles
Biointerphases · 01.01.2021 · 16 (1)
DOI: 10.1116/6.0000540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biointerphases, online erschienen am 17.02.2021. Verfasst von Luca Digiacomo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanodelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome 00161, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Characterization of the personalized protein corona (PC) that forms around nanomaterials upon exposure to human plasma is emerging as powerful technology for early cancer detection. However, low material stability and interbatch variability have limited its clinical application so far. Here, we present a nanoparticle-enabled blood (NEB) test that uses 120 nm gold nanoparticles (NPs) as the accumulator of blood plasma proteins. In the test, the personalized PC of gold NPs is characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis. As a paradigmatic case study, pancreatic ductal adenocarcinoma (PDAC) was chosen due to the lack of effective detection strategies that lead to poor survival rate after diagnosis (<1 year) and extremely low 5-years survival rate (15–20%). Densitometric analysis of 75 protein patterns (28 from healthy subjects and 47 from PDAC patients) allowed us to distinguish nononcological and PDAC patients with good sensitivity (78.6%) and specificity (85.3%). The gold NEB test is completely aligned to affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to end users criteria stated by the World Health Organization for cancer screening and detection. Thus, it could be very useful in clinical practice at the first level of investigation to decide whether to carry out more invasive analyses or not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nanodelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome 00161, Italy.
- General Surgery Unit, University Campus Bio-Medico di Roma, Rome 00128, Italy.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Digiacomo, L., Caputo, D., Coppola, R., Cascone, C., Giulimondi, F., Palchetti, S., Pozzi, D., & Caracciolo, G. (2021). Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles. Biointerphases, 16(1). https://doi.org/10.1116/6.0000540
Vancouver
Digiacomo L, Caputo D, Coppola R, Cascone C, Giulimondi F, Palchetti S, et al. Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles. Biointerphases. 2021;16(1). doi:10.1116/6.0000540
BibTeX
@article{Digiacomo2021,
author = {Digiacomo, Luca and Caputo, Damiano and Coppola, Roberto and Cascone, Chiara and Giulimondi, Francesca and Palchetti, Sara and Pozzi, Daniela and Caracciolo, Giulio},
title = {Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles},
journal = {Biointerphases},
year = {2021},
volume = {16},
number = {1},
doi = {10.1116/6.0000540}
}
EUVIMED